When did PROTALIX BIOTHERAPEUTICS INC (PLX) report earnings last quarter?
PROTALIX BIOTHERAPEUTICS INC (PLX) last reported earnings on 11/13/2025.
PROTALIX BIOTHERAPEUTICS INC (PLX) Earnings History & Surprises
NYSEARCA:PLX • US74365A3095
Current stock price
2.83 USD
+0.04 (+1.43%)
At close:
2.85 USD
+0.02 (+0.71%)
After Hours:
PLX Earnings overview
Past quarterly earnings results for PROTALIX BIOTHERAPEUTICS INC (PLX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 18, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.01
- Revenue Estimate
- 14.503M
Last Reported
Most Recent- Release Date
- Nov 13, 2025
- Period
- Q3 / 2025
- EPS Reported
- $0.03
- EPS Surprise
- -45.99%
- Revenue Surprise
- -1.07%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.03 | 0.06 | -45.99% | - | 17.851M | 18.044M | -1.07% | -0.60% |
| Q2 2025 | 0.00 | 0.03 | -100.00% | 100.00% | 15.658M | 13.681M | 14.45% | 16.21% |
| Q1 2025 | -0.05 | 0.03 | -265.02% | 16.67% | 10.113M | 21.816M | -53.64% | 169.68% |
| Q4 2024 | 0.09 | 0.07 | 27.30% | 228.57% | 18.218M | 18.941M | -3.82% | 73.74% |
| Q3 2024 | 0.03 | 0.04 | -25.74% | 175.00% | 17.959M | 16.421M | 9.37% | 73.60% |
| Q2 2024 | -0.03 | 0.02 | -248.51% | -114.29% | 13.474M | 12.625M | 6.72% | -61.59% |
| Q1 2024 | -0.06 | -0.02 | -197.03% | -20.00% | 3.75M | 9.292M | -59.64% | -60.90% |
| Q4 2023 | -0.07 | -0.03 | -131.02% | - | 10.486M | 5.858M | 79.00% | 21.65% |
| Q3 2023 | -0.04 | -0.07 | 43.42% | 42.86% | 10.345M | 7.716M | 34.07% | -27.05% |
| Q2 2023 | 0.21 | -0.04 | 619.80% | 290.91% | 35.075M | 10.324M | 239.74% | 300.86% |
| Q1 2023 | -0.05 | - | - | 9.59M | - | -40.40% | ||
| Q4 2022 | -0.07 | -0.15 | 53.80% | 53.33% | 8.62M | 6.181M | 39.46% | 0.82% |
| Q3 2022 | -0.07 | -0.15 | 53.80% | 22.22% | 14.18M | 5.752M | 146.52% | 17.68% |
| Q2 2022 | -0.11 | -0.18 | 39.49% | 56.00% | 8.75M | 2.702M | 223.83% | 36.08% |
| Q1 2022 | -0.05 | -0.04 | -23.76% | 64.29% | 16.09M | 15.732M | 2.27% | 42.14% |
| Q4 2021 | -0.15 | -0.11 | -35.01% | -1,600.00% | 8.55M | 7.868M | 8.67% | -56.15% |
| Q3 2021 | -0.09 | -0.12 | 25.74% | 35.71% | 12.05M | 6.969M | 72.91% | 11.68% |
| Q2 2021 | -0.25 | -0.08 | -209.41% | -92.31% | 6.43M | 8.383M | -23.30% | -41.39% |
| Q1 2021 | -0.14 | -0.17 | 18.46% | -240.00% | 11.32M | 11.058M | 2.37% | -47.71% |
| Q4 2020 | 0.01 | -0.09 | 111.65% | - | 19.5M | 12.107M | 61.06% | - |
| Q3 2020 | -0.14 | -0.08 | -73.27% | - | 10.79M | 13.695M | -21.21% | - |
| Q2 2020 | -0.13 | -0.21 | 37.21% | - | 10.97M | 10.982M | -0.11% | - |
| Q1 2020 | 0.10 | -0.30 | 133.00% | - | 21.65M | 6.666M | 224.78% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-90.87%
Max EPS beat (4)
27.30%
Min EPS beat (4)
-265.02%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-8.41%
Max Revenue beat (4)
14.45%
Min Revenue beat (4)
-53.64%
Analysis
In the last 4 quarters, PLX has beaten EPS estimates in 1 out of 4 releases
PLX has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, PLX reported -90.9% below the EPS estimates on average.
In the last 4 quarters, PLX reported -8.4% below the revenue estimates on average.
Related analysis
PROTALIX BIOTHERAPEUTICS INC / PLX Earnings FAQ
Can you provide information on whether PROTALIX BIOTHERAPEUTICS INC beat earnings estimates in the last quarter?
PROTALIX BIOTHERAPEUTICS INC (PLX) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does PLX stock beat earnings estimates?
In the last 4 quarters, PROTALIX BIOTHERAPEUTICS INC (PLX) has beaten EPS estimates in 1 out of 4 releases.